高级搜索
改良FOLFOX方案时辰化疗治疗晚期胃肠癌的临床观察[J]. 肿瘤防治研究, 2011, 38(08): 944-946. DOI: 10.3971/j.issn.1000-8578.2011.08.023
引用本文: 改良FOLFOX方案时辰化疗治疗晚期胃肠癌的临床观察[J]. 肿瘤防治研究, 2011, 38(08): 944-946. DOI: 10.3971/j.issn.1000-8578.2011.08.023
Clinical Observation of Modified FOLFOX Chrono-chemotherapy for Advanced Gastrointestinal Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 944-946. DOI: 10.3971/j.issn.1000-8578.2011.08.023
Citation: Clinical Observation of Modified FOLFOX Chrono-chemotherapy for Advanced Gastrointestinal Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 944-946. DOI: 10.3971/j.issn.1000-8578.2011.08.023

改良FOLFOX方案时辰化疗治疗晚期胃肠癌的临床观察

Clinical Observation of Modified FOLFOX Chrono-chemotherapy for Advanced Gastrointestinal Cancer

  • 摘要: 目的探讨奥沙利铂(L-OHP)联合亚叶酸钙(LV)、5-氟尿嘧啶(5-Fu)的改良FOLFOX时辰化疗方案与L-OHP联合LV、5-Fu的标准FOLFOX4常规化疗方案治疗晚期胃肠癌的近期疗效及不良反应。方法183例晚期胃肠癌患者随机分为时辰化疗组和常规化疗组, 时辰化疗组92例予改良FOLFOX方案时辰化疗, L-OHP 85~100mg/m2,第1天,14∶00~18∶00,正弦曲线式输液泵静脉持续滴注,给药峰值在16∶00;LV 200mg/m2,第1,2天, 22∶00~10∶00;5-Fu 1 000mg/m2 第1,2天,22∶00~10∶00,LV和5-Fu也均用上述正弦曲线式输液泵静脉持续滴注,凌晨04∶00达给药高峰。常规化疗组给予标准的FOLFOX4方案化疗(L-OHP 85~100mg/m2,第1天静滴2小时;LV 200mg/m2,第1,2天静滴2小时;5-Fu 400mg/m2,第1,2天静推,5-Fu 600mg/m2第1,2天持续静滴22小时。L-OHP于上午正常工作时间给药,LV于L-OHP给药结束后给药,5-Fu于LV 结束后给药;两组病例化疗均每2周重复,每30天为1周期,至少2周期后对两组的近期疗效和不良反应进行统计、比较。结果时辰化疗组的有效率为65.2%, KPS评分平均升高分值为18.7,均明显高于常规化疗组(P<0.05)。时辰化疗组的各种不良反应均明显低于常规组(P<0.05)。结论改良时辰化疗方案与常规化疗方案相比有效率明显增高, 不良反应发生率明显降低, 并具有更好的可耐受性, 值得临床推广。

     

    Abstract: ObjectiveTo invasigate the efficacy and side effects differences between modified FOLFOX chrono-chemotherapy with oxaliplatin (L-OHP) combined with 5-fluorouracil (5-Fu) and folinic acid (LV) and standard FOLFOX4 chemotherapy with L-OHP, 5-Fu and LV inadvanced gastrointestinal cancer. MethodsOne hundred and eighty-three patients with advanced gastrointestinal cancer were randomly divided into two groups:chrono-chemotherapy group and conventional -chemotherapy group.Ninety-two patients in chrono-chemotherapy group was infused L-OHP 85~100 mg/m2 from 14:00 to 18:00 (day 1), with the highest plasma drug level at 16:00; LV 200mg/m2 and 5-Fu 1000mg/m2 were administered from 22:00 to 10:00 (day 1~2), with the highest plasma drug level at 4:00 in the morning, using a sinusoidal infusion pump. 91 cases in conventional-chemotherapy group were given standard FOLFOX4 conventional chemotherapy: L-OHP 85~100mg/m2 was infused for 2 hours (day 1); LV 200mg/m2 for 2 hours (day 1~2); 5-FU 400mg/m2 was intravenously injected (day 1~2) and 600mg/m2 infused continuously for 22 hours(day 1~2). L-OHP was administrated at normal working time, followed by LV, and then 5-Fu. Chemotherapy was given repeatedly every 30 days for at least 2 cycles. Result The effective rate in chrono-chemotherapy group was 65.2%, and the KPS score increased by 18.7, which were higher than those of Conventional chemotherapy group (P<0.05). The occurrence of adverse effects was obviously lower than that of conventional chemotherapy group (P<0.05). ConclusionCompared with the conventional chemotherapy regime,modified FOLFOX chrono-chemotherapy had a higher effective rate, lower occurrence of adverse effects and better tolerability, which deserves the clinical expansion.

     

/

返回文章
返回